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Assessing a new Cytotoxicity Test for Material 
Characterization of Single-Use Products 
Alexander Tappe, Elke Jurkiewicz 
 
Sartorius Stedim Biotech GmbH, D-37079 Göttingen, Germany 
BACKGROUND 
In recent years, reduction of mammalian cell growth in single-use (SU) bioreactors and Erlenmeyer shake flasks have been observed, despite the fact that these bioreactors and the respective raw materials to manufacture those SU containers have 
been extensively tested according to existing cytotoxicity standards (e.g. USP<87> and DIN ISO 10993-5). For example, bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP) has been identified in irradiated bioreactor film extracts by Hammond et al. and its 
cytotoxicity has been correlated to cell growth reduction [1, 2]. This enabled suppliers to adjust their manufacturing process and increase the performance of the films, in the case of Sartorius the performance of the new Flexsafe® film [3]. 
While impact of bDtBPP was resolved, the question still remains how this could have been missed and how suppliers can ensure that such incidents will not occur in the future again. To gain a better understanding of the necessary criteria for a 
suitable cell growth standard in biopharma applications we compared the influence of three known cytotoxins on the growth of both L-929 cells, a cell line which is recommended in the USP<87>, and a suspension CHO-DG44 cell line. Assuming 
suppliers of raw material, in particular resins suppliers, have good control on the main ingredients, a suitable growth test would need to identify impacts of minuscule amounts of cytotoxins. 
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All three cytotoxins showed increased cytotoxicities for CHO cells compared to L-929 cells. CHO cells seem to be more suitable for testing of raw materials for biopharma processes. 
These results indicate that serum albumin is impacting the test outcome of the cytotoxicity tests by its extraordinary ligand binding capacity. For a more detailed analysis it would be 
helpful to harmonize both growth tests in equipment involved. Further trials should focus on additional process parameters, in particular cultivation time. 
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EXPERIMENTAL APPROACH 




In this study, three cytotoxins with different modes of cell interactions where used. 
 
Mitomycin C (Fig. 1) inhibits DNA synthesis. It reacts 
covalently with DNA, in vivo and in vitro, forming 
crosslinks between the complementary strands 
of DNA. This prevents the separation of the 




Cycloheximide (Fig. 2) binds to the ribosome and    
blocks translational elongation, thus  




bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP,  
Fig. 3) induces a decrease of the mitochondrial 




Figure 1. Structure of Mitomycin C 
Figure 2. Structure of Cycloheximide 
Figure 3. Structure of bDtBPP 
Cell based assay 
 
Two cell lines were used to compare the effect of the cytotoxins: the adherent L-929 
cell line as recommended in the USP <87>, and a suspension CHO clone (Cellca, D). 
Cells were expanded for one passage before transferring them into multi-well plates 
(MWP). The cytotoxins where dissolved either in DMSO or in phosphate buffer based on 
their dissolubility and added to the medium as a single addition. 
Cells were grown for 1 or 3 days, respectively and afterwards counted with the 
NucleoCounter (CHO) or used for an XTT-Test (L-929). Culture conditions are listed in 













Table 1: Pre-Culture Parameters 




The sensitivity of CHO-DG44 growth test to 
bDtBPP was compared to the L-929 test 
sensitivity (Fig. 4). Due to the dissolubility, 
bDtBPP was dissolved in DMSO, followed by a 
dilution in cell culture medium. 
CHO cell growth was significantly impacted at 
concentrations >0.21 mg/L, and was reduced to 
21% normalized growth (compared to the 
reference) at 0.42 mg/L. According to this results 
an EC50 concentration of approx. 0.3 mg/L was 
determined for CHO-DG44.  
However, L-929 cell growth was only moderately 
affected by 0.21 – 3.36 mg/L bDtBPP. While it 
requires more data to calculate the EC50 it is 
obvious that it is higher than 16.8 mg/L. Separate 
cytotoxicity tests with DMSO confirmed that the 
solvent does not impact the bDtBPP test under 













Figure 4. Dose dependency of bDtBPP-cytotoxicity on CHO-DG44 
and L-929 cell growth. 




Again, DMSO is required as solvent for 
Cycloheximide. Cell proliferation of both cell lines 
is strongly dose-dependent (Fig. 5). In the presence 
of 1 mg/L L-929 cell growth was reduced to 60% 
compared to the reference. For concentrations 
above 1 mg/L the cell growth-interfering influence 
of DMSO has to be examined in more detail, e.g. by 
interference tests. Thus, the EC50 could not be 
calculated from the available data. 
 
In contrast, the proliferation of the CHO-DG44 cell 
line was impacted more strongly by Cycloheximide 
with an EC50 of approx. 0.07 mg/L. At this 
concentrations DMSO does not impact the 
















Figure 5. Dose dependency of Cycloheximide-cytotoxicity on 
CHO DG44 and L-929 cell growth. 




As opposed to the bDtBPP and Cycloheximide, 
Mitomycin C is highly soluble in water and was 
dissolved in PBS buffer. Therefore, an influence 
of a solvent can be ruled out for this test. 
 
As shown with bDtBPP, Mitomycin C (Fig. 6) was 
more toxic to CHO-DG44 than to L-929 cells. 
With an EC50 of 0.05 mg/L Mitomycin C is the 
strongest cytotoxin of the three toxins assessed. 
For the L-929 cells the EC50 is approx. 29 mg/L. 
Until now there is no data available on the other 
toxin to conclude which of the three toxins is 


















Figure 6. Dose dependency of Mitomycin C-cytotoxicity on CHO- 
DG44 and L-929 cell growth. 
Sensitivity to Mitomycin C 
Due to the different cell line specific toxin 
sensitivity the impact of the test conditions need to 
be assessed. One major difference is the use of a 
chemically defined medium for the CHO cells and 
the use of a serum-containing medium for the L-
929 cells. Serum albumin is known for its 
extraordinary ligand binding capacity [4]. 
Therefore, we assessed the impact of serum on the 
CHO test with bDtBPP in the absence and presence 
of different serum concentrations (Fig. 7). The 
result clearly show that the cytotoxic effect of 
bDtBPP can be masked at least up to 0.84 mg/L. It 
is likely that the outcome of the cytotoxicity test 
with the recommended L-929 test is dominated by 













Figure 7. Effect of FBS on the cytotoxicity of bDtBPP during the cell 
growth test. 
Impact of serum on cytotoxicity 
